Build a lasting personal brand

HeartBeam Partners with Mount Sinai to Develop AI-Enhanced ECG Algorithms

By Advos
HeartBeam Inc. has announced a collaboration with Mount Sinai to advance AI-driven ECG technology, aiming to improve remote cardiac monitoring and chronic condition management.

Found this article helpful?

Share it with your network and spread the knowledge!

HeartBeam Partners with Mount Sinai to Develop AI-Enhanced ECG Algorithms

HeartBeam Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care, has entered into a strategic collaboration with Mount Sinai to develop and validate artificial intelligence-based electrocardiogram (ECG) algorithms. The partnership aims to deploy these algorithms broadly across HeartBeam's platform, potentially offering patient-relevant wellness insights, condition-focused assessments, and applications for chronic condition management.

The collaboration was highlighted in a recent article, which noted that the move underscores HeartBeam's growing emphasis on AI-enabled analysis and reinforces the relevance of its technology as healthcare shifts toward data-driven, remote monitoring solutions. According to the publication, the AI models may include a range of applications designed to provide actionable insights for both patients and healthcare providers.

HeartBeam is developing the first cable-free 12-lead ECG capable of capturing the heart's electrical signals from three dimensions. This platform technology is intended for use in portable devices that can be used wherever the patient is, delivering actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to appropriate care outside of a medical facility, potentially redefining the future of cardiac health management.

The company holds 13 U.S. and 4 international issued patents related to its technology enablement. For more information about HeartBeam, visit www.HeartBeam.com.

This partnership comes at a time when remote monitoring and AI-driven diagnostics are increasingly important in healthcare. By combining HeartBeam's innovative ECG technology with Mount Sinai's clinical expertise, the collaboration could accelerate the development of algorithms that help manage chronic cardiac conditions and provide early detection of acute events. The implications for patients include more convenient access to cardiac monitoring and potentially earlier intervention, while healthcare systems may benefit from reduced hospital visits and more efficient resource allocation.

For the latest news and updates relating to HeartBeam, visit the company's newsroom at https://ibn.fm/BEAT.

Advos

Advos

@advos